# Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

> **NCT02099136** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 45 (actual)

## Conditions studied

- No Evidence of Disease

## Interventions

- **PROCEDURE:** UV Light Therapy
- **OTHER:** Placebo
- **DRUG:** Celecoxib
- **PROCEDURE:** Biopsy
- **OTHER:** Imaging Biomarker Analysis

## Key facts

- **NCT ID:** NCT02099136
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2001-09
- **Final completion:** 2004-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099136, "Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02099136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*